Resectable Pancreatic Adenocarcinoma trials recruiting in Indiana

Fewer than 3 recruiting trials found.

All Resectable Pancreatic Adenocarcinoma trials nationally

Cities in Indiana

Recruiting trials in Indiana

• APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
  NCT04858334 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Indiana: Carmel, Crown Point, Dyer, Hobart